What Qualifies as DME? How Manufacturers Prove Durability
One of the most common questions I hear from medical device manufacturers is deceptively simple:
"Can our product qualify as Durable Medical Equipment (DME)?"
The answer matters. DME classification can influence coding strategy, payment pathways, supplier requirements, coverage policies, and ultimately commercial adoption.
Yet many manufacturers focus on technical performance while overlooking one of the foundational requirements of DME status: durability.
The Five Medicare DME Requirements
Under Medicare regulations, an item generally must satisfy five criteria to be considered DME:
It can withstand repeated use.
It is primarily and customarily used to serve a medical purpose.
It is generally not useful to a person in the absence of illness or injury.
It is appropriate for use in the home.
It has an expected lifetime of at least three years.
Most manufacturers understand the medical-purpose requirement. Fewer appreciate how closely CMS and PDAC scrutinize durability.
What Does "Durability" Actually Mean?
Durability is not simply whether a product continues to function after testing. From a Medicare perspective, durability generally means that an item is designed and expected to withstand repeated use over a minimum useful lifetime of three years. This requirement exists because Medicare's DME benefit was historically intended for reusable equipment rather than disposable supplies. A manufacturer may have a highly effective device, but if it is intended for short-term use, frequent replacement, or single-patient episodes of care, it may struggle to qualify as DME.
Common Misconceptions
Misconception #1: FDA Clearance Proves Durability
FDA requirements and DME requirements serve different purposes. FDA testing demonstrates safety and effectiveness. Medicare durability standards evaluate whether an item meets benefit category requirements. A device may be FDA-cleared yet still fail to satisfy Medicare's DME durability expectations.
Misconception #2: Three-Year Warranty Equals Three-Year Durability
A warranty can support a durability argument, but it is not sufficient on its own. CMS and PDAC are typically interested in evidence demonstrating that the product is expected to function for at least three years under normal conditions of use.
Misconception #3: Components Can Be Replaced, Therefore the Product Is Durable
Not necessarily. Many DME products contain replaceable components. The key question is whether the core equipment itself remains functional over the required useful lifetime.
How Manufacturers Can Demonstrate Durability
Manufacturers often assume that durability is self-evident. If a product is engineered to last, the thinking goes, that should be enough. Unfortunately, reimbursement stakeholders rarely accept durability as an assertion. They expect evidence.
1. Start with Design Life and Engineering Documentation
The durability story often begins long before a product reaches the market. During development, manufacturers make decisions about expected service life, reliability targets, maintenance requirements, and component selection. These decisions are typically captured in design controls, engineering specifications, risk management files, and lifecycle analyses. Collectively, this documentation can help demonstrate that a product was intentionally designed to function for at least three years rather than simply survive a short treatment episode. When reimbursement stakeholders evaluate durability, evidence that longevity was a deliberate design objective can be highly persuasive.
2. Generate Meaningful Reliability and Performance Data
Design intent alone is rarely sufficient. Manufacturers should be prepared to support durability claims with testing that reflects how the product will be used in practice. Accelerated life testing, repeated-use simulations, mechanical stress testing, and environmental testing can all help establish whether a device continues to perform as intended over time. The objective is not merely to prove that the product works today, but to demonstrate that it can withstand the demands of repeated use throughout its expected useful life. The more closely testing reflects real-world conditions, the more credible the durability argument becomes.
3. Leverage Real-World Experience and Field Performance
Once a product enters commercial use, real-world data can become one of the strongest forms of evidence. Service records, complaint trends, repair histories, return rates, and utilization data can provide a practical picture of how the device performs outside the controlled environment of a laboratory. In many cases, evidence showing that products remain functional after years of routine use can be more compelling than theoretical projections. Manufacturers that proactively track these metrics often find themselves in a much stronger position when reimbursement questions arise.
4. Ensure Consistency Across Warranties, Service Policies, and Commercial Practices
Reviewers frequently look beyond technical documentation when evaluating durability. Warranty periods, maintenance programs, repair services, and replacement policies all provide clues about how the manufacturer views the product's expected lifespan. If a company claims that a device is durable for three years or more but routinely replaces units after a much shorter period, that inconsistency may raise questions. Conversely, commercial practices that align with the claimed useful life can reinforce the overall durability narrative. Independent third-party testing can provide additional support, particularly when durability becomes a key factor in coding, coverage, or benefit-category determinations.
The most successful manufacturers recognize that durability evidence is not something that can easily be assembled at the last minute. By building a durability dossier throughout development and commercialization, companies can be better prepared to support DME classification and avoid reimbursement delays later in the product lifecycle.
Building the Evidence Before You Need It
One mistake I frequently see is manufacturers waiting until a coding or reimbursement challenge emerges before gathering durability evidence. By that point, generating multiple years of performance data may be impossible.
Instead, manufacturers should begin documenting durability early in development and continue collecting evidence throughout commercialization.
This is particularly important for:
Compression devices
Neuromodulation systems
Home monitoring equipment
Rehabilitation technologies
Respiratory equipment
Advanced wound care devices with reusable components
Durability Documentation on the Path to Market Access
DME classification is not solely a coding exercise—it is fundamentally a benefit-category determination.
As a result, durability often becomes one of the first questions CMS, Medicare contractors, and PDAC reviewers evaluate. Manufacturers that proactively develop engineering, testing, warranty, and real-world evidence supporting a three-year useful life are generally better positioned for DME classification discussions.
When evaluating a reimbursement strategy, manufacturers should ask not only, "Is this product clinically effective?" but also, "Can we convincingly demonstrate that it is durable?"
The answer may have a significant impact on the coding, coverage, and payment pathways available to the technology.
Do you have U.S. commercialization questions?
Whether it's how the multiple payer landscape works in the U.S., how to validate device or procedure coding, timelines associated with product uptake - we're happy to answer them.
Schedule and introductory call: https://calendly.com/nicolecoustier/introductions
